ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat

Journal of Cellular Physiology

Volumn 222, Issue 1, 2010, Pages 82-94

  Ma, Jun ^a   Liang, Shujun ^a   Wang, Zhigang ^a   Zhang, Lei ^a   Jiang, Jing ^a   Zheng, Jinhua ^a   Yu, Lei ^a   Zheng, Xiaodong ^a   Wang, Ruifang ^a   Zhu, Daling ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Bio pharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; CASPASE 3; MESSENGER RNA; NORDIHYDROGUAIARETIC ACID; PROTEIN BAX; RHO KINASE;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY DIAMETER; ARTERY MEDIA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HISTOCHEMISTRY; HOMOGENATE; HYPOXIA; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG ARTERY; LUNG BLOOD VESSEL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SERUM; UPREGULATION;

ANIMALS; APOPTOSIS; ARACHIDONATE 15-LIPOXYGENASE; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL HYPOXIA; CELL SURVIVAL; DNA FRAGMENTATION; DOWN-REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROXYEICOSATETRAENOIC ACIDS; ISOENZYMES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MYOCYTES, SMOOTH MUSCLE; NORDIHYDROGUAIARETIC ACID; ORGAN SIZE; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PULMONARY ARTERY; RATS; RHO-ASSOCIATED KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

RATTUS;

EID: 73949150404     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21923     Document Type: Article

References (38)

1. Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, Takeshita A. 2004. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 94:385-393.
2. Arteaga S, Andrade-Cetto A, Cardenas R. 2005. Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. J Ethnopharmacol 98:231-239.
3. Coleman ML, Olson MF. 2002. Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Differ 9:493-504.
4. Cowan KN, Jones PL, Rabinovitch M. 1999. Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 28:1223-1233.
5. Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, Rabinovitch M. 2000. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6:698-702.
6. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420:629-635.
7. Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, McMurtry IF. 2004. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension inmice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287:L656-L664.
8. Fukumoto Y, Matoba T, Ito A, Tanaka H, Kishi T, Hayashidani S, Abe K, Takeshita A, Shimokawa H. 2005. Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart 91:391-392.
9. Furuyama T, Komori K, Shimokawa H, Matsumoto Y, Uwatoku T, Hirano K, Maehara Y. 2006. Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits. J Vasc Surg 43:1249-1256.
10. Gibbons GH, Dzau VJ. 1994. The emerging concept of vascular remodeling. N Engl J Med 330:1431-1438.
11. Guilluy C, Sauzeau V, Rolli-Derkinderen M, Guerin P, Sagan C, Pacaud P, Loirand G. 2005. Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension. Br J Pharmacol 146:1010-1018.
12. Guo L, Tang X, Tian H, Liu Y, Wang Z, Wu H, Wang J, Guo S, Zhu D. 2008. Subacute hypoxia suppresses Kv3.4 channel expression and whole-cell K+ currents through endogenous 15-hydroxyeicosatetraenoic acid in pulmonary arterial smooth muscle cells. Eur J Pharmacol 587:187-195.
13. Han W, Tang X, Wu H, Liu Y, Zhu D. 2007. Role of ERK1/2 signaling pathways in 4-aminopyridine-induced rat pulmonary vasoconstriction. Eur J Pharmacol 569:138-144.
14. Hattori T, Shimokawa H, Higashi M, Hiroki J, Mukai Y, Kaibuchi K, Takeshita A. 2004. Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice. Circ Res 94:46-52.
15. Hippenstiel S, Schmeck B, N'Guessan PD, Seybold J, Krüll M, Preissner K, Eichel-Streiber CV, Suttorp N. 2002. Rho protein inactivation induced apoptosis of cultured human endothelial cells. Am J Physiol Lung Cell Mol Physiol 283:L830-L838.
16. Humbert M, Sitbon O, Simonneau G. 2004. Treatment of pulmonary arterial hypertension. N Engl J Med 351:1425-1436.
17. Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P. 2005. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 97:185-191.
18. Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Omata M, Kimura S, Fujiwara K. 2003. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 285:G880-G886.
19. Ishikura K, Yamada N, Ito M, Ota S, Nakamura M, Isaka N, Nakano T. 2006. Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circ J 70:174-178.
20. Jernigan NL, Walker BR, Resta TC. 2004. Chronic hypoxia augments protein kinase G-mediated Ca2+ desensitization in pulmonary vascular smooth muscle through inhibition of RhoA/Rho kinase signaling. Am J Physiol Lung Cell Mol Physiol 287:L1220-L1229.
21. Khan I, Oriowo MA, Chandrasekhar B, Kadavil EA. 2005. Attenuated noradrenaline-induced contraction of pulmonary arteries from rats treated with monocrotaline: Role of Rho kinase. J Vasc Res 42:433-440.
22. Kozai T, Eto M, Yang Z, Shimokawa H, Luscher TF. 2005. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway. Cardiovasc Res 68:475-482.
23. Li X, Liu L, Tupper JC, Bannerman DD, Winn RK, Sebti SM, Hamilton AD, Harlan JM. 2002. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. J Biol Chem 277:15309-15316.
24. Li Y, Li Q, Wang Z, Liang D, Liang S, Tang X, Guo L, Zhang R, Zhu D. 2009. 15-HETE suppresses K+ channel activity and inhibits apoptosis in pulmonary artery smooth muscle cells. Apoptosis 14:42-51.
25. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ, Yuan JX. 2004. Cellular and molecular mechanisms of pulmonary vascular remodeling: Role in the development of pulmonary hypertension. Microvasc Res 68:75-103.
26. Moore M, Marroquin BA, Gugliotta W, Tse R, White SR. 2004. Rho kinase inhibition initiates apoptosis in human airway epithelial cells. Am J Respir Cell Mol Biol 30:379-387.
27. Nagaoka T, Fagan KA, Gebb SA, Morris KG, Suzuki T, Shimokawa H, McMurtry IF, Oka M. 2005. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med 171:494-499.
28. Nagaoka T, Gebb SA, Karoor V, Homma N, Morris KG, McMurtry IF, Oka M. 2006. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat. J Appl Physiol 100:996-1002.
29. Natarajan R, Nadler JL. 2003. Lipoxygenases and lipid signaling in vascular cells in diabetes. Front Biosci 8:s783-s795.
30. Pidgeon GP, Tamosiuniene R, Chen G, Leonard I, Belton O, Bradford A, Fitzgerald DJ. 2004. Intravascular thrombosis after hypoxia-induced pulmonary hypertension: Regulation by cyclooxygenase-2. Circulation 110:2701-2707.
31. Porter AG, Janicke RU. 1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6:99-104.
32. Rabinovitch M. 1998. Elastase and the pathobiology of unexplained pulmonary hypertension. Chest 114:213S-224S.
33. Salido M, Gonzalez JL, Vilches J. 2007. Loss of mitochondrial membrane potential is inhibited by bombesin in etoposide-induced apoptosis in PC-3 prostate carcinoma cells. Mol Cancer Ther 6:1292-1299.
34. Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK. 2002. Rho-kinase mediates hypoxia-induced down-regulation of endothelial nitric oxide synthase. Circulation 106:57-62.
35. Uhal BD. 2002. Apoptosis in lung fibrosis and repair. Chest 122:293S-298S.
36. Wang Z, Tang X, Li Y, Leu C, Guo L, Zheng X, Zhu D. 2008. 20-Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells. Eur J Pharmacol 588:9-17.
37. Zhang S, Fantozzi I, Tigno DD, Yi ES, Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ, Yuan JX. 2003. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285:L740-L754.
38. Zhu D, Medhora M, Campbell WB, Spitzbarth N, Baker JE, Jacobs ER. 2003. Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries. Circ Res 92:992-1000.